|
| Exchange Disseminated Time | Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 03, 2015, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2014 (Q3).
Further, as per the Company's Insider Trading Code, the Trading Window for dealing in the securities of the Company would remain closed for all Directors/Officers/Designated Employees of the Company from January 27, 2015 to February 04, 2015 (both days inclusive). |
|
|